|
|
Lupin (Sharekhan) Strong product pipeline provides earnings visibility |
|
Apple Green
Earnings marginally below Street estimates
Performance by geography
Operating margin contracts
Received 4 ANDA approvals during the quarter | Date | Rating | Target Price | Recommendation Price | Broker house | | 2 Aug 2011 | buy | 520 | 458 | Sharekhan Report | |
|
Lupin (Angel) In-line numbers, outlook intact |
| Date | Rating | Target Price | Recommendation Price | Broker house | | 29 Jul 2011 | buy | 593 | 455 | Angel Report | |
|
Lupin (Citi) Steady Quarter; Momentum Should Pick Up in 2H |
|
Remain Positive;1Q Largely In Line;A Better 2H;Several Niche Opportunities Ahead | Date | Rating | Target Price | Recommendation Price | Broker house | | 28 Jul 2011 | buy | 525 | 448 | Citi Report | |
|
Lupin (Credit Suisse) Weak margins; sharp decline in standalone profits |
|
Weak results: Sales in line though margins disappointed;Standalone gross margins declined 780 bp sequentially | Date | Rating | Target Price | Recommendation Price | Broker house | | 28 Jul 2011 | outperform | 480 | 462 | Credit Suisse Report | |
|
Lupin (Deutsche Bank) Largely in-line 1QFY12, while margin pressures continue |
| Date | Rating | Target Price | Recommendation Price | Broker house | | 28 Jul 2011 | hold | 430 | 448 | Deutsche Bank Report | |
|
Lupin (Emkay) Results in-line, Maintain Buy |
|
Q1FY12 revenues grew 17% led by growth across business segments;Cost pre ssure dented operating profitability;Going forward, US business to gain momentum in H2FY12 led by;Operating margins are expected to increase to 20% with launch of new products in US & increase in capacity utilization in new plant at Indore. | Date | Rating | Target Price | Recommendation Price | Broker house | | 27 Jul 2011 | buy | 501 | 448 | Emkay Report | |
|
Lupin (Citi) Results Largely In Line |
|
Revenue Growth Marginally Higher;EBITDA Margin Lower;Recurring Net Profit Higher | Date | Rating | Target Price | Recommendation Price | Broker house | | 27 Jul 2011 | buy | 525 | 448 | Citi Report | |
|
Lupin (Citi) Solid Growth to Continue |
|
Raise TP to Rs525;Multiple Growth Drivers;Big Product Rollout in the US;Emerging Markets & Japan to Remain Strong;Margin Levers Exist | Date | Rating | Target Price | Recommendation Price | Broker house | | 24 Jun 2011 | buy | 525 (from 500) | 430 | Citi Report | |
|
Lupin (ICICIsecurities) Good show against headwinds |
|
Encouraging product pipeline; Plans to launch Suprax drops |
|
lupin (CreditSuisse) Margins continue to be subdued despite strong sales |
Healthy sales trend across geographies; Margins weaker than expected;
| Date |
Rating |
Target Price |
Recommendation Price |
Broker house |
| 16 May 2011 |
outperform |
480 |
423 |
CreditSuisse Report |
Yahoo Link+NSE Link+Reuters Link+Reuters India Link+Google Link+DSR Search
Reports.DesiStockResearch.com |
|
|
|
|
Page 1 of 6 |
